<DOC>
	<DOCNO>NCT03054870</DOCNO>
	<brief_summary>Phase 3 within-subject non-inferiority trial Technegas ventilation image compare Xenon-133 ( Xe-133 ) ventilation image demonstrate non-inferiority Technegas compare Xe-133 ventilation study respect subject pulmonary ventilatory distribution . Subjects undergo site-specific standard care ( SOC ) Xe-133 image per medical need follow Technegas ventilation image per study protocol .</brief_summary>
	<brief_title>A Comparison Technegas Xenon-133 Planar Lung Imaging Subjects Referred Ventilation Scintigraphy</brief_title>
	<detailed_description>This Phase 3 within-subject non-inferiority trial Technegas ventilation image compare Xenon-133 ( Xe-133 ) ventilation image demonstrate non-inferiority Technegas compare Xe-133 ventilation study respect subject pulmonary ventilatory distribution . Subjects undergo site-specific standard care ( SOC ) Xe-133 image per medical need follow Technegas ventilation image per study protocol . Primary assessment efficacy base three blind reader ' assessment Technegas Xe-133 ventilation image independent reading session .</detailed_description>
	<mesh_term>Xenon</mesh_term>
	<criteria>Male female subject least 18 year age . Subject candidate ventilation image . Subject must willing able provide inform consent . Subject must stable able undergo Xe133 planar image Technegas planar imaging . Subject must willing agree complete study procedure , include return 24hour followup safety assessment , physical examination clinical laboratory evaluation . Subject use adequate birth control , female fertile . Adequate birth control define surgical sterilization , hormone contraceptive use intrauterine device ( IUD ) . Female subject childbearing potential negative urine serum pregnancy test . Subject schedule chest Xray within 24 hour prior investigational imaging study . Subject administered radiopharmaceutical within timeframe might cause interference study image . Subject pregnant lactate female . Subject receive Technegas past . Subject receive investigational drug within 30 day prior dose . Subject hemodynamically unstable .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>pulmonary ventilation</keyword>
	<keyword>ventilation scintigraphy</keyword>
</DOC>